Good clinical outcome after ischemic stroke with successful revascularization is time-dependent

Neurology

Volumn 73, Issue 13, 2009, Pages 1066-1072

  Khatri, P ^a   Abruzzo, T ^a   Yeatts, S D ^b   Nichols, C ^a   Broderick, J P ^a   Tomsick, T A ^a  

^a UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPERFUSION; REVASCULARIZATION; RISK BENEFIT ANALYSIS; SCORING SYSTEM; STROKE; SYMPTOM; TIME; TREATMENT OUTCOME;

EID: 70349881711     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181b9c847     Document Type: Article

References (39)

1. Hacke W, Donnan G, Fieschi C, et al, ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363: 768-774.
2. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000;55:1649-1655.
3. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
4. Hacke W, Kaste M, Bluhmki E, et al, ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
5. Wahlgren N, Ahmed N, Eriksson N, et al, for the SITS-MOST Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST). Stroke Epub 2008.
6. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study: a randomized controlled trial: Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011.
7. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-911.
8. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-2135.
9. Smith WS, Sung G, Starkman S, et al, MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-1438.
10. Rha JH, Saver JL. The impact of recanalization on isch-emic stroke outcome: a meta-analysis. Stroke 2007;38: 967-973.
11. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and em-bolic stroke. Ann Neurol 1992;32:78-86.
12. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pes-sin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator: The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3-13. (Pubitemid 23055914)
13. Molina CA, Alvarez-Sabin J, Montaner J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early angiographic reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002;33:1551-1556.
14. Khatri P, Wechsler LR, Broderick JP. ICH associated with revascularization therapies. Stroke 2007;38:431-440.
15. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke: Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-1182.
16. Jahan R. Hyperacute therapy of acute ischemic stroke: in-traarterial thrombolysis and mechanical revascularization strategies. Tech Vas Interv Radiol 2005;8:87-91.
17. McDougall C, Clark W, Mayer T, et al. The Penumbra Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in acute ischemic stroke. Presented at the International Stroke Conference, New Orleans, LA, 2008.
18. Higashida R, Furlan A, Roberts H, et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol 2003;14: S493-S494.
19. Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T, IMS-I Investigators. Revascularization end points in stroke interventional trials: recanalization versus angio-graphic reperfusion in IMS-I. Stroke 2005;36:2400-2403.
20. Khatri P, Hill MD, Palesch YY, et al, for the IMS III Investigators. Methodology of the Interventional Management of Stroke (IMS) III Trial. Int J Stroke 2008;3:130-137.
21. Johnston KC, Connors AF Jr, Wagner DP, Haley EC Jr. Predicting outcome in ischemic stroke: external validation of predictive risk models. Stroke 2003;34:200-202.
22. Henon H, Godefroy O, Leys D, et al. Early predictors of death and disability after acute cerebral ischemic event. Stroke 1995;26:392-398.
23. Wechsler LR, Roberts R, Furlan AJ, et al, PROACT II Investigators. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003;34:1224-1229.
24. König IR, Ziegler A, Bluhmki E, et al. Virtual International Stroke Trials Archive (VISTA) Investigators: predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke 2008;39:1821-1826.
25. Kissela B, Lindsell CJ, Kleindorfer D, et al. Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race. Stroke 2009;40:530-536.
26. Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 2005;36:1447-1451.
27. Ribo M, Alvarez-Sabin J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue angiographic reper-fusion techniques. Stroke 2006;37:1000-1004.
28. Wunderlich MT, Goertler M, Postert T, et al, Duplex Sonography in Acute Stroke (DIAS) Study Group, Competence Network Stroke. Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology 2007;68:1364-1368.
29. Molina CA, Montaner J, Abilleira S, et al. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study. Stroke 2001;32:2821-2827.
30. Christou I, Alexandrov AV, Burgin WS, et al. Timing of re-canalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000;31:1812-1816.
31. Bendszus M, Urbach H, Ries F, Solymosi L. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiol 1998;40:54-58.
32. Zaidat OO, Suarez JI, Sunshine JL, et al. Thrombolytic therapy of acute ischemic stroke: correlation of angio-graphic recanalization with clinical outcome. AJNR Am J Neuroradiol 2005;26:880-884.
33. Wechsler LR, Roberts R, Furlan AJ, et al. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003;34:1224-1229.
34. Zivin JA. Factors determining the therapeutic window for stroke. Neurology 1998;50:599-603.
35. Pancioli AM, Brott TG. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute isch-emic stroke: scientific rationale and available evidence. CNS Drugs 2004;18:981-988.
36. Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007;357:1631-1638.
37. Neumann-Haefelin T, Steinmetz H. Time is brain: is MRI the clock? Curr Opin Neurol 2007;20:410-416.
38. Albers GW, Thijs VN, Wechsler L, et al, DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early angiographic reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-517.
39. Davis SM, Donnan GA, Parsons MW, et al, EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309.